Analysts Set Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Price Target at $29.85

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has been assigned a consensus rating of “Hold” from the fifteen ratings firms that are currently covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a sell recommendation, five have assigned a hold recommendation, seven have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $29.8462.

ACHC has been the subject of several analyst reports. Jefferies Financial Group raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and raised their target price for the company from $24.50 to $30.00 in a research note on Wednesday, June 3rd. Royal Bank Of Canada increased their price target on shares of Acadia Healthcare from $28.00 to $31.00 and gave the company an “outperform” rating in a research note on Monday, May 4th. TD Cowen lifted their price objective on shares of Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Raymond James Financial upgraded shares of Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price objective on the stock in a research note on Monday, May 4th. Finally, Guggenheim upped their target price on shares of Acadia Healthcare from $38.00 to $39.00 and gave the company a “buy” rating in a report on Thursday, July 30th.

Acadia Healthcare Trading Up 3.2%

Shares of NASDAQ:ACHC opened at $27.82 on Wednesday. The firm has a market cap of $2.59 billion, a price-to-earnings ratio of -2.23, a PEG ratio of 8.73 and a beta of 0.64. Acadia Healthcare has a 12 month low of $11.43 and a 12 month high of $35.83. The company’s fifty day simple moving average is $29.97 and its 200 day simple moving average is $25.50. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 1.20.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, topping the consensus estimate of $0.35 by $0.03. The business had revenue of $865.84 million during the quarter, compared to analysts’ expectations of $844.19 million. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The firm’s revenue was down .4% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.83 earnings per share. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. As a group, research analysts forecast that Acadia Healthcare will post 1.54 EPS for the current fiscal year.

Hedge Funds Weigh In On Acadia Healthcare

Several institutional investors and hedge funds have recently modified their holdings of ACHC. EverSource Wealth Advisors LLC grew its stake in Acadia Healthcare by 54.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after buying an additional 497 shares during the last quarter. Allworth Financial LP acquired a new stake in Acadia Healthcare during the second quarter worth approximately $45,000. Wells Fargo & Company MN increased its position in shares of Acadia Healthcare by 208.9% in the fourth quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock worth $32,000 after purchasing an additional 1,510 shares during the period. Global Retirement Partners LLC bought a new position in Acadia Healthcare in the 2nd quarter valued at about $68,000. Finally, Quantbot Technologies LP acquired a new position in Acadia Healthcare during the second quarter valued at approximately $88,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.